VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 22 filers reported holding VASCULAR BIOGENICS LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $15,398 | -69.2% | 128,318 | -60.1% | 0.00% | – |
Q3 2022 | $50,000 | -91.4% | 321,876 | -11.4% | 0.00% | – |
Q2 2022 | $584,000 | +138.4% | 363,135 | +150.3% | 0.00% | – |
Q1 2022 | $245,000 | -24.4% | 145,096 | -11.6% | 0.00% | – |
Q4 2021 | $324,000 | -49.8% | 164,104 | -48.0% | 0.00% | – |
Q3 2021 | $646,000 | +14.7% | 315,313 | +33.8% | 0.00% | – |
Q2 2021 | $563,000 | +310.9% | 235,651 | +244.0% | 0.00% | – |
Q1 2021 | $137,000 | +522.7% | 68,500 | +480.5% | 0.00% | – |
Q4 2020 | $22,000 | +57.1% | 11,800 | +10.3% | 0.00% | – |
Q1 2020 | $14,000 | -6.7% | 10,700 | -32.2% | 0.00% | – |
Q4 2018 | $15,000 | -50.0% | 15,776 | -15.6% | 0.00% | – |
Q3 2018 | $30,000 | -14.3% | 18,684 | +18.2% | 0.00% | – |
Q2 2018 | $35,000 | -80.9% | 15,802 | -80.1% | 0.00% | – |
Q1 2018 | $183,000 | +128.8% | 79,557 | +604.0% | 0.00% | – |
Q4 2017 | $80,000 | +29.0% | 11,300 | -0.1% | 0.00% | – |
Q1 2017 | $62,000 | – | 11,309 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 2,593,286 | $5,751,000 | 0.66% |
Ikarian Capital, LLC | 830,007 | $1,337,000 | 0.24% |
Telemetry Investments, L.L.C. | 118,000 | $190,000 | 0.22% |
Urban Wealth Management, LLC | 12,018 | $19,000 | 0.06% |
DLD Asset Management, LP | 337,300 | $541,000 | 0.04% |
Phoenix Holdings Ltd. | 513,597 | $827,000 | 0.02% |
Caption Management, LLC | 140,000 | $225,000 | 0.00% |
HBK Sorce Advisory LLC | 22,000 | $35,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 79,716 | $128,000 | 0.00% |
Total Clarity Wealth Management, Inc. | 4,000 | $6,000 | 0.00% |